Human IKZF3 ELISA Kit (V2LY-0626-LY5438)

Go to compare Compare Online Inquiry
Tested Data
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Sensitivity
0.0073 ng/mL
Detection Range
0.015-3 ng/mL
Sample Type
Serum, Plasma, cell culture supernates
Specificity
Human
Assay Type
Sandwich
Reactivity
Human
Assay Time
1.5 h
Molecule Mass
58.0 kDa
Components
  • Pre-coated ELISA Plate: 12 wells * 8 detachable strips
  • Standard solution: 0.5ml x1
  • Standard diluent: 3ml x1
  • Streptavidin-HRP: 6ml x1
  • Stop solution: 6ml x1
  • Substrate solution A: 6ml x1
  • Substrate solution B: 6ml x1
  • Wash buffer concentrate (25x): 20ml x1
  • Biotinylated antibody: 1ml x1

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 2-8°C
More Infomation

Target

Full Name
IKAROS family zinc finger 3
Function
Transcription factor that plays an important role in the regulation of lymphocyte differentiation. Plays an essential role in regulation of B-cell differentiation, proliferation and maturation to an effector state. Involved in regulating BCL2 expression and controlling apoptosis in T-cells in an IL2-dependent manner.
Biological Process
B cell activation Source: UniProtKB-KW
Mesoderm development Source: ProtInc
Regulation of apoptotic process Source: UniProtKB
Regulation of B cell differentiation Source: UniProtKB
Regulation of B cell proliferation Source: UniProtKB
Regulation of lymphocyte differentiation Source: UniProtKB
Regulation of transcription by RNA polymerase II Source: GO_Central
Response to bacterium Source: Ensembl
Cellular Location
Nucleus; Cytoplasm
PTM
Phosphorylation on tyrosine residues induced by IL2 is required for dissociation from HRAS and nuclear translocation of IKZF3 in T-cells. Phosphorylation on tyrosine residues induced by IL4 is required for dissociation from Bcl-X(L) in T-cells.

Meng, C., Chen, S., He, Q., Tan, J., Wu, J., & Zhao, J. (2023). IKZF3 modulates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation. International Immunopharmacology, 114, 109480.

Zou, Y., Liu, B., Li, L., Yin, Q., Tang, J., Jing, Z., ... & Chi, T. (2022). IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors. Cancer Letters, 524, 121-130.

Yang, L. K., Lin, C. X., Li, S. H., Liang, J. J., Xiao, L. L., Xie, G. H., ... & Liao, X. (2022). Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis. Frontiers in Genetics, 13, 1036402.

Lazarian, G., Yin, S., Ten Hacken, E., Sewastianik, T., Uduman, M., Font-Tello, A., ... & Wu, C. J. (2021). A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation. Cancer cell, 39(3), 380-393.

Osada, N., Kikuchi, J., Koyama, D., Kuroda, Y., Yasui, H., Leverson, J. D., & Furukawa, Y. (2021). mTOR inhibitors sensitize multiple myeloma cells to venetoclax via IKZF3-and Blimp-1-mediated BCL-2 upregulation. haematologica, 106(11), 3008.

Ridley, M. L., Fleskens, V., Roberts, C. A., Lalnunhlimi, S., Alnesf, A., O’Byrne, A. M., ... & Taams, L. S. (2020). IKZF3/Aiolos is associated with but not sufficient for the expression of IL-10 by CD4+ T cells. The Journal of Immunology, 204(11), 2940-2948.

Vyse, T. J., & Cunninghame Graham, D. S. (2020). Trans-ancestral fine-mapping and epigenetic annotation as tools to delineate functionally relevant risk alleles at IKZF1 and IKZF3 in systemic lupus erythematosus. International Journal of Molecular Sciences, 21(21), 8383.

Dimopoulos, K., Fibiger Munch-Petersen, H., Winther Eskelund, C., Dissing Sjö, L., Ralfkiaer, E., Gimsing, P., & Grønbaek, K. (2019). Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma. Leukemia & lymphoma, 60(1), 180-188.

Awwad, M. H., Kriegsmann, K., Plaumann, J., Benn, M., Hillengass, J., Raab, M. S., ... & Hundemer, M. (2018). The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma. Oncoimmunology, 7(10), e1486356.

Li, L., Ding, X., Wang, X., Yao, Q., Shao, X., An, X., ... & Sun, P. (2018). Polymorphisms of IKZF3 gene and autoimmune thyroid diseases: associated with Graves’ disease but not with Hashimoto’s thyroiditis. Cellular Physiology and Biochemistry, 45(5), 1787-1796.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human IKZF3 ELISA Kit?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.